Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

SWX/MED stock hub

SWX/MED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/MEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

956.1M

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/MED

In the news

Latest news · SWX/MED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E53.8

P25 n/aP50 n/aP75 n/a

Trailing P/E114.8

P25 n/aP50 n/aP75 n/a

ROE3.4

P25 n/aP50 n/aP75 n/a

ROIC0.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/MED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

CHF

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	1,337
Employees Change	388%
Employees Change Percent	40.89
Enterprise value	CHF 1.1B
Exchange	SIX Swiss Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical Devices
Isin	CH0386200239
Last refreshed	2026-05-10
Market cap	CHF 956.1M
Price	CHF 76.9
Price currency	CHF
Rev Per Employee	213,865.77x
Sector	Healthcare
Sic	3842
Symbol	swx/MED
Website	https://www.medartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.87%
EV Earnings	129.5x
EV/EBIT	282.82x
EV/EBITDA	39.42x
EV/FCF	66.96x
EV/Sales	4.02x
FCF yield	1.69%
Forward P/E	53.78x
P/B ratio	3.47x
P/E ratio	114.78x
P/S ratio	3.55x
PE Ratio10 Y	372.36x
PE Ratio3 Y	285.97x
PE Ratio5 Y	476.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.06%
EBITDA Margin	7.27%
FCF margin	6%
Gross margin	75.89%
Gross Profit	CHF 204.3M
Gross Profit Growth	9.29%
Gross Profit Growth Q	19.49%
Gross Profit Growth3 Y	4.82%
Gross Profit Growth5 Y	5.64%
Net Income	CHF 8.3M
Net Income Growth	136.65%
Net Income Growth Q	917.55%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth3 Y	27.46%
Pretax Margin	4.75%
Profit Margin	3.1%
Profit Per Employee	CHF 6,631
Profitable Years	3
ROA	0.35
Roa5y	1.22
ROCE	0.6
ROE	3.42
Roe5y	1.13
ROIC	0.52
Roic5y	2.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	5.2%
Cagr3y	1.15%
Cagr5y	-0.84%
EPS Growth	139.3
EPS Growth Q	1,025.8
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	27.11
FCF Growth	-35.15%
FCF Growth Q	-34.76%
FCF Growth3 Y	-6.14%
OCF Growth	8.56%
OCF Growth Q	15.22%
OCF Growth10 Y	10.69%
OCF Growth3 Y	2.61%
Revenue Growth	19.76x
Revenue Growth Q	29.05x
Revenue Growth Quarters	11x
Revenue Growth Years	5x
Revenue Growth3 Y	6.92x
Revenue Growth5 Y	6.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.53
Assets	CHF 559.9M
Cash	CHF 33M
Current Assets	CHF 195.3M
Current Liabilities	CHF 88.2M
Debt	CHF 158.1M
Debt EBITDA	CHF 5.98
Debt Equity	CHF 0.57
Debt FCF	CHF 9.79
Equity	CHF 275.9M
Interest Coverage	0.38
Liabilities	CHF 284.1M
Long Term Assets	CHF 364.6M
Long Term Liabilities	CHF 195.9M
Net Cash	CHF -125.2M
Net Cash By Market Cap	CHF -13.09
Net Debt EBITDA	CHF 6.4
Net Debt Equity	CHF 0.45
Net Debt FCF	CHF 7.75
Tangible Book Value	CHF 46.9M
Tangible Book Value Per Share	CHF 3.77
WACC	9.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.21
Inventory Turnover	0.73
Net Working Capital	CHF 100.7M
Quick ratio	1.06
Working Capital	CHF 107.1M
Working Capital Turnover	CHF 1.67

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	5.2%
200-day SMA	84.46
3Y total return	3.5%
50-day SMA	80.98
50-day SMA vs 200-day SMA	50under200
5Y total return	-4.11%
All Time High	148.4
All Time High Change	-48.18%
All Time High Date	2022-03-10
All Time Low	31.6
All Time Low Change	143.35%
All Time Low Date	2020-03-23
ATR	3.24
Beta	1.2
Beta1y	0.57
Beta2y	0.88
Ch YTD	-12.81
High	79
High52	97.5
High52 Date	2026-01-26
High52ch	-21.13%
Low	76.2
Low52	71.6
Low52 Date	2025-05-08
Low52ch	7.4%
Ma50ch	-5.03%
Price vs 200-day SMA	-8.95%
RSI	46.45
RSI Monthly	47.81
RSI Weekly	42.75
Sharpe ratio	0.15x
Sortino ratio	0.39
Total Return	-0.32%
Tr YTD	-12.81
Tr1m	-0.9%
Tr1w	1.72%
Tr3m	-13.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 2.8M
Operating Income Growth	-84.54
Operating Income Growth3 Y	-34.82
Operating margin	1.06

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,499,230%
Net Borrowing	10,568,000
Shares Insiders	48.98%
Shares Institutions	9.4%
Shares Out	12,432,612
Shares Qo Q	0.17%
Shares Yo Y	0.32%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 14.6M
Average Volume	6,863.9x
Bv Per Share	22.19
CAPEX	CHF -18.7M
Ch1m	-0.9
Ch1w	1.72
Ch1y	5.2
Ch3m	-13.3
Ch3y	3.5
Ch5y	-4.11
Ch6m	2.67
Change	-1.28%
Change From Open	-2.66
Close	77.9
Days Gap	1.41
Depreciation Amortization	16,725,000
Dollar Volume	300,525.2
Earnings Date	2026-08-18
EBIT	CHF 2.8M
EBITDA	CHF 19.6M
EPS	CHF 0.67
F Score	6
FCF	CHF 16.1M
FCF EV Yield	1.49x
FCF Per Share	CHF 1.3
Financing CF	6,833,000
Fiscal Year End	December
Founded	1,997
Goodwill	165,395,700
Graham Number	18.28946
Graham Upside	-76.22
Income Tax	CHF 3.5M
Investing CF	-146,262,000
Is Primary Listing	1
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Lynch Fair Value	CHF 16.75
Lynch Upside	-78.22
Ma150	83.86
Ma150ch	-8.29%
Ma20	77.79
Ma20ch	-1.14%
Net CF	-105,720,000
Next Earnings Date	2026-08-18
Open	79
P FCF Ratio	59.21
P OCF Ratio	27.46
Position In Range	25
Ppne	94,060,000
Price Date	2026-05-08
Price EBITDA	CHF 48.85
Ptbv Ratio	20.38
Relative Volume	0.57x
Revenue	269,257,000x
SBC By Revenue	0.58x
Share Based Comp	1,560,000
Tax By Revenue	1.28x
Tax Rate	27%
Tr6m	2.67%
Volume	3,908
Z Score	2.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SWX/MED pay a dividend?

Capital-return profile for this ticker.

Performance

SWX/MED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/MED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.4%

Share of float held by funds and institutions

Insider ownership

+49.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

SWX/MED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

1.20

Moves roughly with the market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/MED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/MED stock rating?

swx/MED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/MED analysis?

The full report lives at /stocks/swx/MED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/MED?

The latest report frames swx/MED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/MED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.